26 May 2026

strategyland.uk

Burberry Group PLC (BRBY)

Rank #30 of 100 - Consumer Cyclicals - UK Equities

Home/Stocks/Consumer Cyclicals

Burberry Group PLC

BRBY.L·Consumer Cyclicals·Market Cap £4.1b

Rank #30 of 100

Data from Excel Model · 100 Stocks Analysed

£11.03

-10.95% YTD

Target: £13.31(+20.7%)

52W: £9.39 - £13.77

Score Analysis

Burberry Group PLC is ranked #30 out of 100 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

59/100

Average Score

Liquidity

Excellent14/100

Valuation

Good29/100

Profitability

Fair47/100

Solvency

Weak74/100

Asset Efficiency

Fair59/100

Mkt Trading

Weak92/100

Technical

Weak95/100

1. Valuation

Score: 29/100

Is BRBY undervalued compared to its peers and fair value metrics?

1/5

valuation criteria met

✗

FY26e P/E Ratio

28.3xRank 89/100

✗

FY27e P/E Ratio

19.7xRank 86/100

✗

Price-to-Book

3.94xRank 62/100

✗

Price-to-Tangible Book

5.10xRank 51/100

✓

EV/EBITDA

8.5xRank 34/100

Key Valuation Metrics

Current P/E

197.9x

Price-to-Earnings

FY26e P/E

28.3x

Forward estimate

FY27e P/E

19.7x

Forward estimate

P/B Ratio

3.94x

Price-to-Book

P/TBV

5.10x

Price-to-Tangible Book

EV/EBITDA

8.5x

Enterprise Value

FY26e EV/EBITDA

7.7x

Forward estimate

FY27e EV/EBITDA

7.7x

Forward estimate

Analyst Consensus Target

Current Price

£11.03

Consensus Target

£13.31

Potential

+20.7%

Target

Bloomberg Median Target: £14.00

2. Profitability

Score: 47/100

How profitable is BRBY relative to its peers?

2/6

profitability criteria met

✓

TTM Profit Margin

0.8%Rank 8/100

–

Current ROE

2.3%

–

Current ROA

N/A

✓

FY26e EPS

0.57Rank 28/100

–

TTM EPS

0.41

–

Net Income Growth

N/A

Profit Margin

0.8%

ROE

2.3%

FY27e ROE

17.5%

ROA

N/A

Earnings Per Share

3. Financial Health

Score: 74/100

How strong is BRBY's balance sheet and financial position?

1/4

solvency criteria met

–

Debt-to-Equity

161.0%

–

Interest Coverage

N/A

✓

Debt/EBITDA

Rank 25Rank 25/100

–

Altman Z-Score

2.47

Key Health Metrics

Quick Ratio

1.36

Healthy

Cash Ratio

1.87

Debt/Equity

161%

FCF Margin

1.0%

Altman Z-Score

2.47

Grey Zone

01.812.995+

4. Asset Efficiency

Score: 59/100

How efficiently does BRBY deploy its assets and intellectual capital?

0/2

asset efficiency criteria met

–

Intangible/Asset

Intangible assets as a proportion of total assets — lower indicates more tangible, capital-efficient operations

N/A

–

R&D/Sales

Research & development spend relative to revenue — balanced R&D investment signals sustainable growth

N/A

Overall Asset Efficiency Rank

Rank within sector peers#59/100

Best (1)Worst (100)

What This Measures

Intangible/Asset — a lower ratio suggests the company's value is backed by tangible assets rather than goodwill or intangibles, reducing balance sheet risk.

R&D/Sales — captures the proportion of revenue reinvested into research and development, indicating innovation intensity and future growth investment.